Use and abuse of oxytocin for augmentation of labor

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 12, 2009, Pages 1352-1357

  Selin, Lotta ^a,b   Almström, Elisabeth ^a   Wallin, Gunnar ^c   Berg, Marie ^b  

^a NU Hospital Group   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cesarean section; Labor dystocia; Oxytocin augmentation; Prolonged labor

Indexed keywords

OXYTOCIN;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DRUG ABUSE; DRUG USE; DYSTOCIA; FEMALE; GESTATION PERIOD; HUMAN; LABOR INDUCTION; LABOR ONSET; MAJOR CLINICAL STUDY; PARITY; PREGNANCY OUTCOME; PRIORITY JOURNAL;

ADULT; CESAREAN SECTION; DYSTOCIA; FEMALE; HUMANS; INFANT, NEWBORN; OXYTOCICS; OXYTOCIN; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 72049115524     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016340903358812     Document Type: Article

References (29)

1. O'Driscoll K, Meagher D, Robson M. Active Management of Labour. USA: Elsevier Limited; 2003.
2. El-Hamamy E, Arulkamaran S. Poor progress of labour. Curr Obstet Gynaecol. 2005;15:1-8.
3. National Board of Health and Welfare. Centre of Epidemiology. Kejsarsnitt i Sverige 1990-2001. Cesarean section in Sweden 1990-2001. Publication no.2005-112-113 Accessed 2005 (in Swedish). Available at: http://www. socialstyrelsen. se/Publicerat/2005/8750/2005-112-3.htm.
4. Florica M, Stephansson O, Nordstrom L. Indications associated with increased cesarean section rates in a Swedish hospital. Int J Gynaecol Obstet. 2006;92:181-185
5. Kjaergaard H, Olsen J, Ottesen B, Nyberg P, Dykes AK. Obstetric risk indicators for labour dystocia in nulliparouswomen: a multi-centre cohort study. BMC Pregnancy Childbirth. 2008;8:45.
6. National Board of Health and Welfare. Handläggning av normal förlossning. Management of Normal Delivery: A State of the Art Document. Publication no. 2001-123-131 Accessed 2001 (in Swedish). Available at: http://www.sfog.se/PDF/ 2001-123-1.PDF
7. Alfirevic Z, Edwards G, Platt MJ. The impact of delivery suite guidelines on intrapartum care in 'standard primigravida'. Eur J Obstet Gynecol Reprod Biol. 2004;115:28-31.
8. Oscarsson ME, Amer-Wahlin I, Rydhstroem H, Kallen K. Outcome in obstetric care related to oxytocin use. A population-based study. Acta Obstet Gynecol Scand. 2006;85:1094-1098
9. Hayes EJ, Weinstein L. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin. Am J Obstet Gynecol. 2008;198:622-627
10. National Board of Health and Welfare. Available at: http:// www.socialstyrelsen.se/Statistik/statistikdatabas/.
11. Blix E, Pettersen SH, Eriksen H, Royset B, Pedersen EH, Oian P. Use of oxytocin augmentation after spontaneous onset of labor. Tidsskr Nor Laegeforen. 2002;122:1359-1362
12. Svardby K, Nordstrom L, Sellstrom E. Primiparas with or without oxytocin augmentation: a prospective descriptive study. J Clin Nurs. 2007;16:179-184
13. Blix-Lindstrom S, Johansson E, Christensson K. Midwives' navigation and perceived power during decision-making related to augmentation of labour. Midwifery. 2008;24:190-198
14. Lavender T, Hart A, Smyth RM. Effect of partogram use on outcomes for women in spontaneous labour at term. Cochrane Database Syst Rev. 2008;4:CD005461.
15. Hinshaw K, Simpson S, Cummings S, Hildreth A, Thornton J. A randomised controlled trial of early versus delayed oxytocin augmentation to treat primary dysfunctional labour in nulliparous women. BJOG. 2008;115:1289-1295
16. Dencker A, Berg M, Bergqvist L, Ladfors L, Thorsen LS, Lilja H. Early versus delayed oxytocin augmentation in nulliparous women with prolonged labour-a randomised controlled trial. BJOG. 2009;116:530-536
17. Blanch G, Lavender T, Walkinshaw S, Alfirevic Z. Dysfunctional labour: a randomised trial. Br J Obstet Gynaecol. 1998;105:117-120
18. Lavender T, Alfirevic Z, Walkinshaw S. Partogram action line study: a randomised trial. Br J Obstet Gynaecol. 1998;105:976-980
19. Nystedt A, Hogberg U, Lundman B. Some Swedish women's experiences of prolonged labour. Midwifery. 2006;22:56-65.
20. American college of obstetrics and gynecology. ACOG practice bulletin number 49, December 2003:Dystocia and augmentation of labor. Int J Gynaecol Obstet. 2004;85:315-324
21. Lopez-Zeno JA, Peaceman AM, Adashek JA, Socol ML. A controlled trial of a program for the active management of labor. N Engl J Med. 1992;326:450-454
22. Xenakis EM, Langer O, Piper JM, Conway D, Berkus MD. Low-dose versus high-dose oxytocin augmentation of labor-a randomized trial. Am J Obstet Gynecol. 1995;173:1874-1878
23. Pattinson RC, Howarth GR, Mdluli W, Macdonald AP, Makin JD, Funk M. Aggressive or expectant management of labour: a randomised clinical trial. BJOG. 2003;110:457-461
24. Jonsson M, Norden-Lindeberg S, Ostlund I, Hanson U. Acidemia at birth, related to obstetric characteristics and to oxytocin use, during the last two hours of labor. Acta Obstet Gynecol Scand. 2008;87:745-750
25. Clark S, Belfort M, Saade G, Hankins G, Miller D, Frye D, et al. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes. Am J Obstet Gynecol. 2007;197:480-485
26. Satin AJ, Leveno KJ, Sherman ML, Brewster DS, Cunningham FG. High- versus low-dose oxytocin for labor stimulation. Obstet Gynecol. 1992;80:111-116
27. Akoury HA, MacDonald FJ, Brodie G, Caddick R, Chaudhry NM, Frize M. Oxytocin augmentation of labor and perinatal outcome in nulliparas. Obstet Gynecol. 1991;78:227-230
28. Kjaergaard H, Olsen J, Ottesen B, Dykes AK. Incidence and outcomes of dystocia in the active phase of labor in term nulliparous women with spontaneous labor onset. Acta Obstet Gynecol Scand. 2009;88:402-407
29. Selin L, Wallin G, Berg M. Dystocia in labour - risk factors, management and outcome: a retrospective observational study in a Swedish setting. Acta Obstet Gynecol Scand. 2008;87:216-221